Lv51
926 积分 2023-05-10 加入
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
11天前
已完结
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
12天前
已完结
Prognostic Impact of Monoallelic Versus Biallelic TP53 Alterations in Intensively-Treated Adults AML Patients: A Retrospective Study from the ALFA Group
20天前
已关闭
A clinical guide to TP53 mutations in myeloid neoplasms
25天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
Lupus nephritis
1个月前
已完结
皖公网安备34019202002308
